To evaluate therapeutic product candidates in bacterial in vitro hollow fiber models.
Ended Awarded Last action
- Contract number
- 75N93021F00001
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $462,052
Award facts
- Opportunity
-
- A17 Solicitation number
- Contract value 36% obligated
-
- $462,052.00 Current, with exercised options
- $1,275,123.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35255, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $462,052 |
About this award
This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the Southern Research Institute, a corporate entity tax-exempt non-profit organization. The contract is a Delivery Order under the In Vitro Assessments of Antimicrobial Activity (IVAAA) Indefinite Delivery/Indefinite Quantity (ID/IQ) contract vehicle. The $1,275,123.00 cost-plus-fixed-fee contract is for evaluating therapeutic product candidates in bacterial in vitro hollow fiber models. This work supports NIAID's mission of conducting and supporting research to understand, treat, and prevent infectious diseases. The contract does not have a set-aside designation and is scheduled to be completed by August 11, 2023.
Quick answers
Who was awarded contract 75N93021F00001?
75N93021F00001 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 16, 2021.
How much is contract 75N93021F00001 worth?
The government has obligated $462,052 on 75N93021F00001. Its potential value, with all options, is $1,275,123.
Is contract 75N93021F00001 an order under another contract?
Yes. 75N93021F00001 is a delivery order under 75N93019D00014, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93021F00001 competed?
The extent of competition for 75N93021F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award